NTRA Q3 2020 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$28B

Q3 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$98M+26.0% YoY

Gross Profit

$46M47.2% margin

Operating Income

-$56M-56.8% margin

Net Income

-$58M-59.4% margin

EPS (Diluted)

$-0.72

QoQ Revenue Growth

+13.5%

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$35M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$977M

Total Liabilities

$441M

Stockholders' Equity

$536M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$98M	$78M	+26.0%
Gross Profit	$46M	$34M	+36.1%
Operating Income	-$56M	-$21M	-164.4%
Net Income	-$58M	-$23M	-152.1%

Revenue Segments

Product

$93M95%

Licensing And Other

$5M5%

Geographic Segments

U

$94M95%

E M E A

$4M4%

Americas Excluding Us

$1M1%

Other Geographic Areas

$27,0000%